Skip to content

Patient-Applied Pretreatment Analgesia for Intrauterine Device Placement

Patient-Applied Pretreatment Analgesia for Intrauterine Device Placement

Status
UNKNOWN
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05890495
Acronym
PAP-AID
Enrollment
120
Registered
2023-06-06
Start date
2023-06-30
Completion date
2024-01-31
Last updated
2023-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contraception

Keywords

Long-Acting Reversible Contraception

Brief summary

The goal of this clinical trial is to perform a pilot study looking at the benefit of topical anesthetic application to the cervix by tampon prior to intra-uterine device insertion. The main question it aims to answer are: * Does patient tampon-applied local anesthetic prior to insertion of an intrauterine device (IUD) reduce procedural duration? * Does patient tampon-applied local anesthetic prior to insertion of an intrauterine device (IUD) reduce pain and improve patient perceptions of the procedure? Participants will place a tampon after dipping the tampon into the study-supplied medication (aqueous lidocaine or saline). Researchers will compare treatment and control groups to see if there is any difference in procedure time, difficulty or patient perceptions.

Detailed description

This Pilot Randomized Double Blind Clinical Trial study will assess the effectiveness of patient-applied aqueous lidocaine via tampon as a pre-treatment prior to intra-uterine device placement. Subjects will apply the lidocaine or a saline placebo to the end of a standard tampon with a plastic applicator and then place the tampon 1 hour prior to the procedure. The tampon will be removed as the subject prepares for the procedure. The procedure team will measure the procedure time as well as the subject and provider impressions of the procedure. This data will be evaluated to compare the lidocaine to the control group.

Interventions

4% aqueous solution

DEVICETampon

Tampon with plastic applicator provided

Sponsors

American Academy of Family Physicians National Research Network
CollaboratorNETWORK
Uniformed Services University of the Health Sciences
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Masking description

Study medication provided per randomization table. Study participants allocated sequentially. Subject and provider blinded to allocation

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 54 Years
Healthy volunteers
Yes

Inclusion criteria

* Request IUD insertion * Age 18 or older * Willingness to return for procedure after completing virtual study consent

Exclusion criteria

* Known allergy to viscous lidocaine or tampons * Current vaginal or cervical injury

Design outcomes

Primary

MeasureTime frameDescription
Procedure timeMeasured during procedureTime from uterine sounding to cutting strings (to allow for procedures where an IUD is removed prior to placing a new IUD)
Patient-reported pain levelObtained immediately after the procedure prior to the patient leaving the clinic0-10 Visual analog scale

Secondary

MeasureTime frameDescription
Patient-reported satisfaction with procedureObtained immediately after the procedure prior to the patient leaving the clinic0 - 100%
Patient-reported interest in subsequent procedureObtained immediately after the procedure prior to the patient leaving the clinicLikert scale
Provider-reported procedural difficultyObtained immediately after the procedure prior to the patient leaving the clinicLikert scale

Countries

United States

Contacts

Primary ContactMichael J Arnold, MD
michael.arnold@usuhs.edu301-295-9853
Backup ContactSajeewanee E Seales, MD
sajeewane.seales@usuhs.edu301-295-9853

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026